A Win For CNS Pharmaceuticals, Inc.
Thu, Feb 04, 2021 at 05:30 PM
CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) soared at $3.5, a gain of 68.3%. The stock appeared on our News Catalysts scanner on Tue 12 Jan 21 at 11:58 AM in the 'BIOTECH' category. From Wed 20 Jan 21, the stock recorded 60.00% Up Days and 18.18% Green Days
The stock spiked on Mon 25 Jan 21 at $2.23 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About CNS Pharmaceuticals, Inc. (CNSP:NASDAQ)
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Top 10 Gainers:
- ATA Creativity Global (AACG:NASDAQ), 936.23%
- Lizhi Inc. (LIZI:NASDAQ), 70.47%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 68.27%
- CYTH (CYTH:NASDAQ), 59.39%
- Midatech Pharma plc (MTP:NASDAQ), 47.29%
- Veru Inc. (VERU:NASDAQ), 44.39%
- Meten EdtechX Education Group Ltd. (METX:NASDAQ), 44.21%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 43.64%
- DAVIDsTEA Inc. (DTEA:NASDAQ), 42.24%
- SANA (SANA:NYSE), 40.4%